Agios Pharmaceuticals Aktie
29,60
EUR
-0,20
EUR
-0,67
%
34,16
USD
+1,10
USD
+3,32
%
Agios Pharmaceuticals jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Agios Pharmaceuticals Aktie Analyse
| 15.02.18 | Agios Pharmaceuticals Buy | Needham & Company, LLC | |
| 15.09.17 | Agios Pharmaceuticals Outperform | RBC Capital Markets | |
| 10.08.17 | Agios Pharmaceuticals Buy | Needham & Company, LLC | |
| 24.10.16 | Agios Pharmaceuticals Buy | Needham & Company, LLC | |
| 18.05.16 | Agios Pharmaceuticals Buy | SunTrust Robinson Humphrey, Inc. | |
| 30.03.16 | Agios Pharmaceuticals Buy | SunTrust Robinson Humphrey, Inc. | |
| 22.07.15 | Agios Pharmaceuticals Outperform | Northland Capital | |
| 18.02.15 | Agios Pharmaceuticals Buy | MLV Capital | |
|
Werbung
|
|||
| 04.12.14 | Agios Pharmaceuticals Buy | MLV Capital | |
| 19.11.14 | Agios Pharmaceuticals Buy | Canaccord Adams | |
| 12.11.14 | Agios Pharmaceuticals Buy | Canaccord Adams | |
Werbung
Werbung